MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
Li LuoDenghui WeiYihui PanQiu-Xia WangJian-Xiong FengBing YuTiebang KangJunhang LuoJiefeng YangSong GaoPublished in: Cancer communications (London, England) (2023)
Our findings uncover an important non-canonical mitochondria-dependent pathway regulating EGFR signaling by the Rab21-MFN2-PTPRJ axis, which contributes to the development of novel therapeutic strategies for ccRCC.